Meanwhile, the activity of calcium/calmodulin-dependent protein kinase II was upregulated in resistant glioma cells and its cDNA transfection in sensitive glioma cells lead to glioma cells resistance, indicating that CaMK II may be involved in malignant glioma cell resistance [18]. The gene discussed is CAMK2G; the disease is central nervous system cancer.